| AE | Adverse event |
| ALT | Alanine transaminase |
| AST | Aspartate aminotransferase |
| AUA | American Urological Association |
| BPH | Benign prostatic hyperplasia |
| DBP | Diastolic blood pressure |
| HO-1 | Heme oxygenase 1 |
| IIEF | International Index of Erectile Function |
| IPSS | International Prostate Symptom Score |
| LOCF | Last observation carried forward |
| LUTS | Lower urinary tract symptom |
| MFDS | Ministry of Food and Drug Safety |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| PPS | Per protocol set |
| PSA | Prostate-specific antigen |
| QoL | Quality of life |
| ROS | Reactive oxidative species |
| SAE | Serious adverse event |
| SAGX | Salvia miltiorrhiza extract |
| SBP | Systolic blood pressure |